A Makerere University College of Health Sciences (CHS) team of researchers led by Dr. Richard Idro, in collaboration with Ministry of Health (MoH) - National Malaria Control Division (NMCD) and other several partner institutions conducted a study to investigate whether post discharge malaria chemoprevention could enhance morbidity andn mortality in children following in-hospital treatment for severe malaria. One of the key findings is the 70% reduction in all cause re-admission or death following monthly administration of Dihydroartemisinin-piperaquine (DP) for 3 months as post discharge chemoprevention.
On Thursday 3rd December, 2020, the study results will be published in the New England Journal of Medicine (NEJM). On the same day, MoH-NMCD and CHS have jointly organised a National Dissemination and Policy Dialogue Meeting of these research findings with key stakeholders.
Time: 9:00am - 12:00pm (EAT)
For on-site (designated guests), all the MoH SOPs for mitigating the spread of COVID-19 shall be adhered to.
Join Zoom Meeting
Meeting ID: 960 8966 3094
Dr. Aggrey Dhabangi
Transfusion Medicine Specialist
Child Health and Development Centre,
Makerere University, College of Health Sciences